Navigation Links
AviaraDx Confirms That Combination of Two Molecular Biomarkers Improves Prediction of Disease Recurrence in Early Stage Breast Cancer Patients
Date:5/13/2008

oliferation gene signatures are essentially redundant, and they do not go beyond ER/PR in determining the likelihood of responding to endocrine therapy," said Antonius Schuh, PhD, chief executive officer of AviaraDx, Inc. "H/I and MGI together provide a more complete diagnostic picture that should help clinicians make more appropriate treatment decisions for their breast cancer patients."

"This is the first analysis linking H/I to our new, five-gene tumor grading index, MGI," said Mark Erlander, PhD, chief scientific officer for AviaraDx, Inc. "For patients whose tumors have high MGI values, it is important to measure H/I in order to determine likely benefit from endocrine therapy within the setting of a highly proliferating tumor."

The authors conclude that these two markers together should enable oncologists to identify a large subgroup of women with low risk of recurrence who may be spared from toxic chemotherapy regimens. In addition, they may also identify a significant population of patients for whom intensive chemotherapy regimens or new therapeutic agents should be considered.

"As molecular diagnostics enable the personalization of patient care, we will help patients and clinicians determine appropriate therapies and avoid both over- and under-treatment," added Schuh.

Approximately 100,000 women present with ER-positive, node-negative breast cancer in the United States every year. The data included in this month's Clinical Cancer Research publication show that the combination of Aviara MGI and Aviara H/I provides objective information to better assess both recurrence risk and potential for response to systemic therapies in these early stage breast cancer patients. The combination of these two biomarkers is now commercially available as the Aviara Breast Cancer Index(SM).

About AviaraDx, Inc.

AviaraDx discovers, develops, and commercializes new molecular diagnostic tests in oncology, enabling physicians to personalize
'/>"/>

SOURCE AviaraDx, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Study Confirms Dose-Accuracy of SoloSTAR(R) Prefilled Insulin Pen
2. Interim Analysis of Phase I/II Study of Rexin-G Confirms Efficacy With No Dose Limiting Toxicity in Metastatic Pancreatic Cancer
3. FDA Confirms Seizure of Eyelash Product Was Not Prompted by Reports of Adverse Effects
4. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
5. Study Confirms That New Protocol Shortens the Time It Takes to Open Blocked Arteries for Heart Attack Patients
6. IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients
7. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
8. CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic
9. Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine
10. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
11. Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... Oct. 20, 2014  Indianapolis interventional medical device ... Toronto -based 3D visualization leader Synaptive ... Neurological Surgeons Annual Meeting that they have joined ... surgery. The collaboration is the first of its ... improve patient outcomes. NICO,s BrainPath® interventional access technology ...
(Date:10/20/2014)... , Oct. 20, 2014  AnaptysBio, Inc., a ... antibodies, today announced the appointment of Marco ... Londei will lead the preclinical and clinical development ... "We are pleased to welcome Dr. Londei to ... , President and Chief Executive Officer of AnaptysBio. ...
(Date:10/20/2014)... -- Norgine B.V. today announced that the ... preparation, NER1006, presented at the 79 th Annual ... Philadelphia, PA , has met its ... endpoint of cleansing success. The study demonstrated high quality ... in screening colonoscopy patients. [1] (Logo: ...
Breaking Medicine Technology:Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 2Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 3Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 4Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 5AnaptysBio Appoints Dr. Marco Londei to Newly Created Chief Development Officer Position Clinical Immunologist to Lead AnaptysBio's Pipeline Advancement 2Positive Results from Phase II Data Show NER1006 Achieves High Quality Bowel Cleansing Efficacy 2
(Date:10/20/2014)... PA (PRWEB) October 20, 2014 ... Matthew Voicheck as Assistant Director of their ... role in managing the innovative turnkey drug sourcing, ... , Matthew brings over 12 years of industry ... joins Myoderm at the peak of their international ...
(Date:10/20/2014)... October 20, 2014 Final Cut Pro X ... of the Citrus theme for FCPX filmmakers . , ... to describe the Citrus theme” Says Christina Austin, CEO of ... look so professional.” , Citrus comes with all the tools ... template are: four transitions for added style, a title screen ...
(Date:10/20/2014)... Spring, Maryland, USA (PRWEB) October 20, 2014 ... or to track interventions? Here comes a wonderful app ... mobile app development company helped its client ... Intervention more efficiently. The app is designed for iOS ... and iPod touch. This app is optimized for iPhone ...
(Date:10/19/2014)... (PRWEB) October 20, 2014 This ... for Partial Seizure, complete with comparative analysis at ... of action (MoA), route of administration (RoA) and ... news and press releases. It also reviews key ... Seizure and special features on late-stage and discontinued ...
(Date:10/19/2014)... (PRWEB) October 19, 2014 Visual ... program has just been released to the public ... online body building and fitness community. The commotion ... of DietsAndFitnessGuides.com's Vin Delmonico prompting an investigative review. ... of hitting what is commonly known as a ...
Breaking Medicine News(10 mins):Health News:Myoderm Hires Matthew Voicheck to Lead Turnkey Drug Sourcing Service 2Health News:Today Pixel Film Studios Announced the Release of the Citrus theme for Final Cut Pro X 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 4Health News:Visual Impact Frequency Training Review: Rusty Moore's Latest Fitness Guide Released 2
... mental health needs of juvenile offenders should be treated as ... hope of rehabilitation, according to new research from the University ... review of previous studies into the health of young offenders ... The results of the review have been published in ...
... took capsules equivalent to brewed beverage, , FRIDAY, June 19 ... slow the progression of prostate cancer, the results of a ... to 72 years old, who had prostate cancer and were ... a day of an investigational agent called Polyphenon E, an ...
... Whole Body Radiosurgery , , SUNNYVALE, Calif., June 19 ... leader in the field of radiosurgery, announced today that the ... Systems for installation in Ankara and Istanbul, Turkey. , ... Center in January 2005. A second system was installed in ...
... Hargaalga Snr. Discusses How to Reform Personalities Enduring Metaphysical ... 19 The question of whether intelligence is hereditary ... questions arising from research studies that show cognitive differences ... Over Control: Without Physical Violence" ( published by ...
... the acquisition of the Micron Catheter from private owners ... , , (Logo: http://www.newscom.com/cgi-bin/prnh/20090217/NE70925LOGO ... provides the opportunity to offer our customers another exceptional ... NeuroTherm. NeuroTherm has an established distribution network currently ...
... Narconon Gulf Coast, a world-class substance abuse ... Florida, announces the graduation of its 300th student. Narconon ... Ross after undergoing multiple unsuccessful attempts with other rehabilitation ... , *(PHOTO 72dpi: www.Send2Press.com/mediaboom/09-0619-NarcononFL_72dpi.jpg ) , ...
Cached Medicine News:Health News:Young offenders' health critical to rehabilitation 2Health News:Young offenders' health critical to rehabilitation 3Health News:Green Tea Component May Slow Prostate Cancer 2Health News:Turkish Ministry of Health Purchases Two CyberKnife(R) Systems 2Health News:Turkish Ministry of Health Purchases Two CyberKnife(R) Systems 3Health News:Provocative New Nonfiction Addresses Spiritual Destiny 2Health News:Provocative New Nonfiction Addresses Spiritual Destiny 3Health News:NeuroTherm Completes Acquisition of the Micron Epidural Catheter 2Health News:Narconon Gulf Coast Announces 300th Graduate From Drug Rehabilitation Program 2
... Edgeahead Stiletto / MVR knife. 1.1 mm (19G) ... 1.1 mm (19G) Cannula (5/bx, 1 bx/ca). State-of-the-art ... consistently sharp and precise. Sure grip handles have ... tip creates a fluid tight incision for self-sealing ...
... Renu Multiplus No Rub formula is the ... today. All steps in one bottle without ... stores soft contact lenses and removes protein ... multi-purpose solution that contains Hydranate, a special ...
... new level of comfort by enhancing ... the lens and the delicate surface ... sodium hyalunorate, an ingredient that replicates ... eye. With a naturally disappearing preservative, ...
Specially formulated to lubricate and moisten lenses to help relieve irritation and dryness....
Medicine Products: